Impact of H19 Polymorphisms on Prostate Cancer Clinicopathologic Characteristics
Active surveillance is the preferred strategy for very low risk, low risk, and some favorable intermediate risk of prostate cancer. However, the current risk stratifications with initial prostate-specific antigen (iPSA) levels and Gleason scores at biopsy can underestimate the true oncologic threat....
Main Authors: | Ju-Chuan Hu, Chia-Yen Lin, Shian-Shiang Wang, Kun-Yuan Chiu, Jian-Ri Li, Chuan-Shu Chen, Sheng-Chun Hung, Cheng-Kuang Yang, Yen-Chuan Ou, Chen-Li Cheng, Shun-Fa Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/10/9/656 |
Similar Items
-
Associations between LncRNA <i>MALAT1</i> Polymorphisms and Lymph Node Metastasis in Prostate Cancer
by: Ju-Chuan Hu, et al.
Published: (2021-09-01) -
Geriatric Nutritional Risk Index as a Prognostic Marker for Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel
by: Li-Wen Chang, et al.
Published: (2021-01-01) -
Impacts of CA9 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.
by: Shian-Shiang Wang, et al.
Published: (2013-01-01) -
Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel
by: Jian-Ri Li, et al.
Published: (2017-11-01) -
Robotic assisted laparoscopic radical prostatectomy following transurethral resection of the prostate: perioperative, oncologic and functional outcomes
by: Chi-Feng Hung, et al.
Published: (2014-06-01)